About
Biodesix Inc (NASDAQ:BDSX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
Mar 20 2026
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
Feb 26 2026
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Feb 12 2026
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Jan 12 2026
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
Financials
Revenue
$88.5 M
Market Cap
$151.42 M
EPS
-4.67
Translate